Mainz

Mainz 55131

0 studies enrolling now · 2 studies all time

What they study most

Cirrhosis, Heart Failure With Preserved Ejection Fraction, Non-alcoholic Steatohepatitis, Portal Hypertension, Pulmonary Hypertension

Studies at this site

• A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study) — Running, not enrolling
• Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension — Completed